Literature DB >> 15294969

Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.

Toshiyuki Takaki1, Scott M Lieberman, Thomas M Holl, Bingye Han, Pere Santamaria, David V Serreze, Teresa P DiLorenzo.   

Abstract

The NOD mouse is a model for autoimmune type 1 diabetes in humans. CD8(+) T cells are essential for the destruction of the insulin-producing pancreatic beta cells characterizing this disease. AI4 is a pathogenic CD8(+) T cell clone, isolated from the islets of a 5-wk-old female NOD mouse, which is capable of mediating overt diabetes in the absence of CD4(+) T cell help. Recent studies using MHC-congenic NOD mice revealed marked promiscuity of the AI4 TCR, as the selection of this clonotype can be influenced by multiple MHC molecules, including some class II variants. The present work was designed, in part, to determine whether similar promiscuity also characterizes the effector function of mature AI4 CTL. Using splenocyte and bone marrow disease transfer models and in vitro islet-killing assays, we report that efficient recognition and destruction of beta cells by AI4 requires the beta cells to simultaneously express both H-2D(b) and H-2K(d) class I MHC molecules. The ability of the AI4 TCR to interact with both H-2D(b) and H-2K(d) was confirmed using recombinant peptide libraries. This approach also allowed us to define a mimotope peptide recognized by AI4 in an H-2D(b)-restricted manner. Using ELISPOT and mimotope/H-2D(b) tetramer analyses, we demonstrate for the first time that AI4 represents a readily detectable T cell population in the islet infiltrates of prediabetic NOD mice. Our identification of a ligand for AI4-like T cells will facilitate further characterization and manipulation of this pathogenic and promiscuous T cell population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294969     DOI: 10.4049/jimmunol.173.4.2530

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.

Authors:  Gayatri Mukherjee; Ari Geliebter; Jeffrey Babad; Pere Santamaria; David V Serreze; Gordon J Freeman; Kristin V Tarbell; Arlene Sharpe; Teresa P DiLorenzo
Journal:  Int Immunol       Date:  2013-09-10       Impact factor: 4.823

2.  Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.

Authors:  Deanna Lamont; Gayatri Mukherjee; P Rajesh Kumar; Dibyendu Samanta; Caroline G McPhee; Thomas W H Kay; Steven C Almo; Teresa P DiLorenzo; David V Serreze
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

3.  B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.

Authors:  Jun Sik Lee; Lisa Scandiuzzi; Anjana Ray; Joyce Wei; Kimberly A Hofmeyer; Yael M Abadi; P'ng Loke; Juan Lin; Jianda Yuan; David V Serreze; James P Allison; Xingxing Zang
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

4.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

5.  Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.

Authors:  Arunika Mukhopadhaya; Tadashi Hanafusa; Irene Jarchum; Yi-Guang Chen; Yoshiko Iwai; David V Serreze; Ralph M Steinman; Kristin V Tarbell; Teresa P DiLorenzo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-22       Impact factor: 11.205

6.  Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.

Authors:  Rodolfo José Chaparro; Amanda R Burton; David V Serreze; Dario A A Vignali; Teresa P DiLorenzo
Journal:  J Immunol Methods       Date:  2008-04-08       Impact factor: 2.303

7.  Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.

Authors:  J Babad; G Mukherjee; A Follenzi; R Ali; B O Roep; L D Shultz; P Santamaria; O O Yang; H Goldstein; D L Greiner; T P DiLorenzo
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

8.  Deletion of the G6pc2 gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein does not affect the progression or incidence of type 1 diabetes in NOD/ShiLtJ mice.

Authors:  James K Oeser; Vrajesh V Parekh; Yingda Wang; Naresh K Jegadeesh; Suparna A Sarkar; Randall Wong; Catherine E Lee; Lynley D Pound; John C Hutton; Luc Van Kaer; Richard M O'Brien
Journal:  Diabetes       Date:  2011-09-06       Impact factor: 9.461

9.  Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette.

Authors:  John P Driver; Felix Scheuplein; Yi-Guang Chen; Alexandra E Grier; S Brian Wilson; David V Serreze
Journal:  Diabetes       Date:  2009-11-10       Impact factor: 9.461

10.  Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.

Authors:  Yi-Guang Chen; Felix Scheuplein; Melissa A Osborne; Shirng-Wern Tsaih; Harold D Chapman; David V Serreze
Journal:  Diabetes       Date:  2008-09-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.